Neuroendoscopy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Product (Rigid Neuroendoscopes and Flexible Neuroendoscopes), Application, Usability, and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Neuroendoscopy is performed using an endoscope on the end to allow the neurosurgeon to navigate and access the tumor. In order to remove a tumor or take a sample of it (a biopsy), neurosurgeons attach special instruments to the endoscope, often an additional endoscope with forceps and scissors on the end, as opposed to conventional open brain surgery, which requires more time for healing post-surgery and induces less pain. Also, neuroendoscopic procedures cause minimal scarring in patients. These benefits are being considered widely in the medical community and therefore, these procedures are becoming more common worldwide. Hence, the benefits of neuroendoscopic surgery over conventional brain surgery are expected to drive the growth of the market. Other factors that will affect the growth of this market include rising prevalence of neurological disorders and favorable government initiatives.

Scope of the Report

As per the scope of the report, Neuroendoscopy is a minimally invasive surgical procedure in which the neurosurgeon removes the tumor through small holes in the skull or through the mouth or nose.

By Product
Rigid Neuroendoscopes
Flexible Neuroendoscopes
By Application
Transnasal Neuroendoscopy
Intraventricular Neuroendoscopy
Transcranial Neuroendoscopy
By Usability
Reusable Neuroendoscopes
Disposable Neuroendoscopes
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Rigid Neuroendoscope Segment is Expected to Show Better Growth in the Forecast Period

Based on the product, the market is segmented into a rigid neuroendoscope and flexible neuroendoscope.  Rigid neuroendoscopes are used for the treatment of diseases such as cystic lesions, hydrocephalus, and intraventricular tumors. The better growth of this segment is attributed to the increasing prevalence of neurological diseases and the rising application of rigid endoscopes in intraventricular neuroendoscopy. In addition, these devices are cost-effective and are available in  smaller sizes. According to the American Cancer Society, in 2019, around 23,820 adults in the United States were diagnosed with primary cancerous tumors of the brain and spinal cord. Hence, the rising number of brain tumor cases, along with growing demand for minimally invasive surgical procedures are expected to fuel the market growth.

Central Nervous System Biomarkers Market 1

North America is Estimated to Dominate the Neuroendoscopy Market

North America currently dominates the market and is expected to continue the same trend. The neuroendoscopy market is mainly driven by factors, such as rising government initiatives, and increasing prevalence of neurological disorders. According to a report published on Annals of Neurology, in 2017, around 100 million people in the US are suffering from neurological disorders such as alzheimer's, multiple sclerosis, migraines, epilepsy, and spinal cord injury. Furthermore, with the rising concerns regarding neurological disorders and increasing healthcare expenditure, the market is expected to grow over the forecast period.

Neuroendoscopy Market 2

Competitive Landscape

The global players in the neuroendoscopy market are Adeor Medical AG, B. Braun Melsungen AG, Clarus Medical, KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd., Schindler Endoskopie Technologie GmbH and Tonglu Wanhe Medical Instrument Co., Ltd.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Neurological Disorders

      2. 4.2.2 Benefits of Neuroendoscopic Surgery over Conventional Brain Surgery

      3. 4.2.3 Favorable Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Rigid Neuroendoscopes

      2. 5.1.2 Flexible Neuroendoscopes

    2. 5.2 By Application

      1. 5.2.1 Transnasal Neuroendoscopy

      2. 5.2.2 Intraventricular Neuroendoscopy

      3. 5.2.3 Transcranial Neuroendoscopy

    3. 5.3 By Usability

      1. 5.3.1 Reusable Neuroendoscopes

      2. 5.3.2 Disposable Neuroendoscopes

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Adeor Medical AG

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Clarus Medical

      4. 6.1.4 KARL STORZ SE & Co. KG

      5. 6.1.5 Machida Endoscope Co., Ltd.

      6. 6.1.6 Schindler Endoskopie Technologie GmbH

      7. 6.1.7 Tonglu Wanhe Medical Instrument Co., Ltd

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Neuroendoscopy Market market is studied from 2018 - 2026.

The Neuroendoscopy Market is growing at a CAGR of 4.0% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Adeor Medical AG, B. Braun Melsungen AG, Clarus Medical, KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd. are the major companies operating in Neuroendoscopy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!